moxifloxacin has been researched along with cloxacillin in 5 studies
| Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (cloxacillin) | Trials (cloxacillin) | Recent Studies (post-2010) (cloxacillin) |
|---|---|---|---|---|---|
| 3,157 | 552 | 1,690 | 1,715 | 155 | 177 |
| Protein | Taxonomy | moxifloxacin (IC50) | cloxacillin (IC50) |
|---|---|---|---|
| Beta-lactamase | Escherichia coli | 0.026 | |
| Efflux transporter | Salmonella enterica subsp. enterica serovar Newport | 0.004 | |
| Beta-lactamase | Klebsiella pneumoniae | 0.004 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arvieux, C; Bugnon, D; Caillon, J; Grossi, O; Hamel, A; Jacqueline, C; Potel, G | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for moxifloxacin and cloxacillin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
4 other study(ies) available for moxifloxacin and cloxacillin
| Article | Year |
|---|---|
In vivo efficacy of moxifloxacin compared with cloxacillin and vancomycin in a Staphylococcus aureus rabbit arthritis experimental model.
Topics: Animals; Anti-Bacterial Agents; Arthritis, Experimental; Arthritis, Infectious; Aza Compounds; Cloxacillin; Colony Count, Microbial; Fluoroquinolones; Half-Life; Methicillin Resistance; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Rabbits; Staphylococcal Infections; Vancomycin | 2007 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |